Background The polygenic risk score (PRS) is derived from single nucleotide polymorphisms (SNPs) including those that are genome-wide significant and also including a large number of others more weakly associated with schizophrenia. Such variants are widely dispersed, though concentrated near genes expressed in the brain, and it has been proposed that these SNP associations result from impacts on cell regulatory networks that ultimately affect the expression or function of a modest number of 'core' genes. A previous study showed association of some genome-wide association study-significant variants with expression of a number of genes, by examining pairwise correlations of gene expression with SNP genotypes.
Introduction
There is a substantial genetic contribution to the aetiology of schizophrenia, which in part manifests as association with common variants, with over 100 loci meeting conventional standards for significance in a genome-wide association study (GWAS) (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014). The same study showed that a polygenic risk score (PRS) was more strongly predictive of schizophrenia if it included not only the variants that were statistically significant but also many other variants with only weak evidence for association. This clearly showed that there are a very large number of common variants whose frequency differs between cases and noncases. In a recent review of this field, the authors noted the previous evidence for the involvement of large numbers of variants that were very widely distributed across the genome and proposed that the term 'omnigenic' could appropriately be used (Boyle et al., 2017) . However, in their own analyses, they demonstrated that only variants near genes expressed in the brain contribute substantially to heritability of schizophrenia and that variants near genes expressed specifically in the brain made a larger contribution per variant than those near more widely expressed genes. They also noted that common variants show only a modest enrichment for genes by functional category and contrasted this with the findings from studies of rare variants and copy variant numbers that implicate synaptic and neuronal genes Purcell et al., 2014; Marshall et al., 2016) . Although they did not refer to it, an additional study of ultra-rare, gene disruptive variants also showed enrichment in these categories (Genovese et al., 2016) . To make sense of these observations, they proposed that a given phenotype might be directly affected by a modest number of 'core' genes but that, because cell regulatory networks are highly interconnected, any expressed gene is likely to have some effect on the regulation or function of these core genes.
A previous study sought to investigate the relationship between common variants and gene expressions by examining single nucleotide polymorphism (SNP) genotypes and RNAseq results from the dorsolateral prefrontal cortex (DLPFC) . This reported that about 20% of schizophrenia-associated loci contained variants that could contribute to altered gene expression or liability. Considering SNP-gene pairs within 1 Mb of each other, there were 2 154 331 significant cis-eQTLs, and these were enriched for enhancer sequences in brain tissues, most strongly in DLFPC enhancers. There were also 45 453 significant trans-eQTLs, in which the SNP was more than 1 Mb from the gene whose expression it correlated with. Only pairwise comparisons of SNPs and genes were carried out and there was no report of whether the expression of any genes correlated with the PRS, although it was reported that the PRS was higher in cases than controls.
If multiple common variants exert their effect indirectly through regulatory networks, it is plausible that the PRS might reflect a cumulative effect on the expression of one or more 'core' genes. This cumulative effect on gene expression might be greater than any pairwise effect on expression because of a single SNP. Also, it might be more pronounced for the expression of the core genes themselves than for the genes that only exerted their effect indirectly and so could serve to focus attention on core genes. Hence, it seems logical to explore whether the schizophrenia PRS is associated with gene expression.
Materials and methods
The dataset used in the previous gene expression study was .
Genotypes and expression levels were available for 258 patients with schizophrenia and 279 controls. The distributions of ethnicities were reported to be similar between patients with schizophrenia and controls (White 80.7%, African-American 14.7%, Hispanic 7.7%, East Asian 0.6%). The methods for obtaining the genotypes and expression data have been described by the authors of the original study . Genotyping was performed on the Illumina Infinium HumanOmniExpressExome 8v 1.1b chip (Catalogue no.: WG-351-2301) using the manufacturer's protocol. QC was performed using Plink to remove markers with zero alternate alleles, genotyping call rate less than 0.98, Hardy-Weinberg P value of less than 5 × 10 − 5
, and individuals with genotyping call rate less than 0.90. Marker alleles were phased to the forward strand and ambiguously stranded markers have been removed. The gene expression data had been obtained by RNA sequencing of tissue from the DLPFC followed by adjustment for ancestry and other appropriate covariates.
To obtain a PRS for schizophrenia, the file called scz2.prs.txt.gz, containing odds ratios (ORs) and P values for 102 636 SNPs, was downloaded from the Psychiatric Genetics Consortium (PGC) website (http://www.med.unc.edu/pgc/results-and-down loads). This training set was produced as part of the previously reported PGC2 schizophrenia GWAS (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014). SNPs with P value less than 0.05 were selected and their log(OR) summed over sample genotypes using the -score function of Plink 1.09beta to produce a PRS for each patient (http://www. cog-genomics.org/plink/1.9/ ) (Purcell et al., 2007 (Purcell et al., , 2009 Chang et al., 2015) . The first 20 principal components for all genotyped SNPs were produced using the -pca and -makerel functions of Plink.
Statistical tests and data manipulation were carried out using R, version 3.3.2 (R Core Team, 2014).
Initial analyses showed that the PRS was higher in cases than controls (t = 3.5, P = 0.00059), but it was noticed that the association became much more highly significant when the SNP principal components were included as covariates (P = 2.5 × 10 − 17
). This seemed to be because of the fact that the first principal component was very strongly negatively correlated with the PRS (r = − 0.81, P = 1.2 × 10 − 126 ). This correlation was present in both the controls (r = − 0.85, P = 1.8 × 10
) and the cases (r = − 0.80, P = 2.5 × 10 − 59
). The plots of controls and cases of the first and the second principal components are shown in Fig. 1a and b, respectively. It can be seen that the distribution is similar in both groups. Most patients have a very high value for the first principal component and a very low value for the second one, but several patients are clearly outliers from this main grouping and have low scores for the first principal component or, in a few cases, high scores for the second. To filter out these outliers, the dataset was narrowed to include patients with the first principal component value greater than 0.01 and the second principal component value less than 0.04. Doing this excluded 51 controls and 72 cases, leaving 207 controls and 209 cases, and produced a more homogeneous sample in which the PRS was not significantly correlated with the first principal component but was very significantly higher in cases than controls (t = 8.3, P = 1.3 × 10
).
Regression of the expression level of each of the 16 423 genes was performed on the PRS including the 20 principal components as covariates. The minus log base 10 of the P value (MLP) was recorded for each gene, as was the signed log P value (SLP), which is the same as the MLP, but gives a positive sign if the regression coefficient is positive and a negative sign if the coefficient is negative.
In addition to the analyses based on individual genes, gene set analyses were performed to see whether it was possible to identify a set of genes whose expression tended to correlate with the PRS. Two lists of gene sets were used. The first consisted of the 32 gene sets reported to be enriched for ultra-rare, gene disruptive variants in a sample of exomesequenced schizophrenia cases (Genovese et al., 2016) . These included categories such as genes expressed in neurons, genes near GWAS hits and genes that are loss of function intolerant. The second group consisted of 1454 'all GO gene sets, gene symbols' pathways downloaded from the Molecular Signatures Database at http://www.broad institute.org/gsea/msigdb/collections.jsp (Subramanian et al., 2005) .
It is challenging to detect whether the expression pattern of a set of genes correlates with the PRS. One cannot simply test whether genes in the set are more strongly correlated with PRS than those not in the set, because it is expected that the expression patterns of genes within a set will correlate with each other so that their correlations with PRS are not expected to be independent. Nor can one test whether the mean or total expression of members of the set correlates with PRS, because it is expected that if a biological effect is present then expression of some genes will be increased and others decreased. Instead, the MLPs for each gene in the set MLP, the minus log base 10 of the P value.
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were summed and the total compared with that which would be expected by chance by carrying out permutations of the PRS across patients and then recalculating and totalling the gene-wise MLPs for each permuted dataset. The proportion of times the totalled MLPs for permuted datasets exceeded the total for the real dataset was used to obtain an empirical P value, and minus log base 10 of this empirical P value was used to obtain an MLP for the gene set.
Results
The Q : Q plot for the SLPs for the correlation of PRS with the expression of each of 16 423 genes are shown in Fig. 2 . It can be seen that the results almost exactly follow what would be expected under the null hypothesis if the expression patterns of the genes were independent. The most highly significant correlation was for SULF1 with P value of 0.000005 (MLP = 5.3), but this would not reach conventional standards of significance if a Bonferroni correction was applied. SULF1 codes for an extracellular heparan sulphate endosulfatase and does not seem to be a likely candidate for involvement in the aetiology of schizophrenia. It could be argued that expression patterns of genes are likely to be correlated with each other and that a Bonferroni correction might be overly conservative. Table 1 lists the genes achieving MLP greater than 3. (Fagerberg et al., 2014) brain 0.00 Bound by CELF4 (Wagnon et al., 2012) celf4 0.18 Missense-constrained (Samocha et al., 2014) constrained 0.34 Involved in developmental disorder (Deciphering Developmental Disorders Study, 2017) dd 0.34 De-novo variants in autism denovo.aut 1.05 De-novo variants in coronary heart disease denovo.chd 0.08 De-novo variants in epilepsy denovo.epi 0.34 De-novo duplications in ASD (Kirov et al., 2012) denovo.gain.asd 0.38 De-novo duplications in bipolar disorder (Kirov et al., 2012) denovo.gain.bd 0.11 De-novo duplications in schizophrenia (Kirov et al., 2012) denovo.gain.scz 0.65 De-novo variants in intellectual disability denovo.id 0.18 De-novo deletions in ASD (Kirov et al., 2012) denovo.loss.asd 1.04 De-novo deletions in bipolar disorder (Kirov et al., 2012) denovo.loss.bd 0.86 De-novo deletions in schizophrenia (Kirov et al., 2012) denovo.loss.scz 0.04 De-novo variants in schizophrenia denovo.scz 0.87 Bound by FMRP (Darnell et al., 2011) fmrp 0.20 Implicated by GWAS (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014) gwas 0.92 Targets of microRNA-137 (Robinson et al., 2015) mir137 2.17 Expression specific to neurons (Cahoy et al., 2008) neurons 0.71 NMDAR and ARC complexes (Kirov et al., 2012) nmdarc 0.04 Loss-of-function intolerant (Lek et al., 2016) pLI09 0.41 PSD-95 (Bayés et al., 2011) psd95 0.18 Bound by RBFOX 1 or 3 (Weyn-Vanhentenryck et al., 2014) rbfox13 0.04 Bound by RBFOX 2 (Weyn-Vanhentenryck et al., 2014) rbfox2 0.26 Synaptic (Pirooznia et al., 2012) synaptome 0.15 Escape X-inactivation (Cotton et al., 2013) x.escape 0.04 X-linked intellectual disability, Genetic Services Laboratories of the University of Chicago (Moeschler et al., 2006; Rauch et al., 2006; Moeschler, 2008; Gécz et al., 2009) xlid.chicago 0.32 X-linked intellectual disability, Greenwood Genetic Centre (Moeschler et al., 2006) xlid.gcc 0.36 X-linked intellectual disability, OMIM (Hamosh et al., 2005) xlid.omim 0.32
The definition of each set is provided in the online methods section of the original publication (Genovese et al., 2016) . GWAS, genome-wide association study; MLP, the minus log base 10 of the P value. GO, gene ontology; MLP, the minus log base 10 of the P value. Table 2 shows the permutation-derived MLPs for each of the gene sets previously used to test for enrichment for damaging ultra-rare variants. It can be seen that none of the sets produces highly significant evidence for correlation with PRS. For only two of the sets, alid and mir137, does the MLP exceed 2 and again these results would not be significant if a Bonferroni correction was applied. Again, it could be argued that this might be conservative because the sets overlap each other and hence the MLPs, although individually valid, are not independent.
Of the 1454 gene ontology gene sets, none produced a result that would be significant after Bonferroni correction. However, 11 did produce MLPs exceeding 3 and these are listed in Table 3 . Again, these are not independent but include overlapping sets of genes. In particular, the sets relating to histone modification contain RBM14, which has a gene-wise MLP of 3.42, whereas the regulation of cell differentiation sets include MAFB, which has a gene-wise MLP of 3.19. Table 4 lists all the genes that occur in at least one of these sets and that have a gene-wise MLP greater than 1.3, equivalent to P value less than 0.05.
Discussion
This approach has failed to yield any genes or gene sets whose expression is strongly associated with the schizophrenia PRS. It would be possible to argue that the Bonferroni correction is overly conservative and that there may be some association, but the main aim of the analysis, to provide a strong focus on a small set of 'core' genes, has not been successful. The PRS represents a cumulation of genetic risk factors from multiple locations, but it is not the case that the variants involved exert their effects on risk primarily by combining to affect the expression of a small number of genes. It is of course possible that there is some association between the PRS and the expression of some genes that would be possible to detect whether a larger sample was available. In terms of effects on gene expression, the analyses described here do not add anything to the results previously reported for pairwise analyses .
As an aside, it is worth noting the very strong correlation of the schizophrenia PRS with the first principal component of the ethnically heterogeneous sample. It has recently been noted that the PRS for schizophrenia stratifies by ancestry (Weiner et al., 2017) . Likewise, the PRS for type 2 diabetes and coronary heart disease vary between populations and this must be taken account of if attempting to estimate an individual's risk (Reisberg et al., 2017) . Although it may be expected that the mean PRS will vary somewhat according to the ethnicity, it is perhaps a little surprising that the observed correlation with the first principal component is quite so strong and this will be the subject of further investigation. However, this phenomenon does not seem to be relevant to the findings reported here, which were obtained from the more homogeneous subsample.
This study does not support the proposal that multiple common variants exert a joint effect on schizophrenia risk through a cumulative effect on the expression of a small number of genes. It is not hard to conceive of different mechanisms whereby the 'polygenic risk' might be observed. One kind of mechanism is that a variant has some effect on the gene function or the expression that has a small but direct effect on the pathophysiological processes that can lead to schizophrenia. However, one can also conceive of indirect effects that could be very distant from the 'core biology'. There are a number of environmental factors that appear to influence the risk of schizophrenia, including obstetric complications, cannabis use, maternal viral infection, maternal malnutrition and childhood adversity (Cannon et al., 2002; Xu et al., 2009; Khandaker et al., 2013; Stilo et al., 2013; Gage et al., 2017) . Any genetic variant that affects exposure to such risk factors will be expected to be associated with schizophrenia and these mechanisms may work either within the proband or within their parents. To give one example, as pointed out previously, smoking during pregnancy is a risk factor for the subsequent development of schizophrenia and the observed genetic association between smoking behaviour and schizophrenia might be mediated through this mechanism, so that a genetic predisposition to smoke in the mother is associated with increased risk of schizophrenia in her offspring (Niemel et al., 2016; Curtis, 2017; Hartz et al., 2017) . Likewise, genetic GO, gene ontology; MLP, the minus log base 10 of the P value.
Polygenic risk score for schizophrenia Curtis 63 variants that influence pelvis size, foetal head size, susceptibility to viral infection, cannabis preference and susceptibility to be either a victim or perpetrator of childhood abuse will all be expected to be associated with schizophrenia risk. Of course, such indirect effects may be very small, but GWAS sample sizes are such that very small effects can be detected. If this view is valid then a number of common variants may contribute to the 'omnigenic' signal through indirect environmental mechanisms as well as through the interactive effects in intracellular and intercellular networks that have been proposed (Boyle et al., 2017) .
